Advicenne Reaches a Significant Milestone With the US FDA in the Development of ADV7103 in Cystinuria
Advicenne (Euronext Growth Paris ALDVI – FR0013296746) a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suffering from rare ...
BBC17d
The ultra-fast cancer treatments which could replace conventional radiotherapy
A pioneering new treatment promises to tackle a wider range of cancers, with fewer side-effects than conventional radiotherapy. It also takes less than a second. In a series of vast underground ...
Medscape18d
Acquired Fanconi's syndrome associated with monoclonal gammopathies.
The osteomalacia is caused by chronic hypophosphatemia and may be exacerbated by secondary hyperparathyroidism and renal tubular acidosis. Treatment consists of supplementation with phosphorus ...
Nature24d
Fanconi syndrome articles from across Nature Portfolio
Fanconi syndrome is a hereditary or acquired disease of the renal ... tubular wasting of nutrients and salts, which are released into the urine. Clinical features include hypokalaemia, acidosis ...